title: Neonatal urticaria due to prostaglandin E1.
abstract: Prostaglandin E1 is commonly used in the management of cyanotic congenital heart disease. While cutaneous flushing and peripheral edema are well recognized side effects of prostaglandin E1 therapy, other cutaneous effects have not been described in the dermatologic literature. We report a neonate with transposition of the great vessels who developed urticaria during treatment with prostaglandin E1.
authors.affiliation: Department of Dermatology, Columbia University, College of Physicians and Surgeons, New York, New York, USA.
authors.forename: E L
authors.initials: EL
authors.lastname: Carter
authors.forename: M C
authors.initials: MC
authors.lastname: Garzon
mesh_terms: D000527:Alprostadil / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D014581:Urticaria / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects*
chemical_list: D014665:Vasodilator Agents; D000527:Alprostadil